Lung cancer is one of the most common types of cancer worldwide, with approximately 2 million cases diagnosed in About ArcherDX ArcherDX is a leading genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. We develop and commercialize research use only RUO products, are developing in vitro diagnostic IVD products, and offer services that meet the unique needs of our customers and their clinical applications.
ArcherDX is headquartered in Boulder, Colorado. Learn more at www. Forward-Looking Statements This press release may contain forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of All statements contained in this press release other than statements of historical fact, are forward-looking statements. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors.
ArcherDX has based these forward-looking statements largely on its current expectations and projections about future events and trends. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. Moreover, ArcherDX operates in a competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for its management to predict all risks, nor can it assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements it may make.
ArcherDX undertakes no obligation to revise or publicly release the results of any revision to such forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.
CA Cancer J Clin. Lung Cancer ; Chronic Dis Transl Med ; 3 3 Cancer Res ;β8. Career Advice. Show Search. Search Query Submit Search. ArcherDX, Inc.
